Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioHarvest Sciences Inc. (BHST) had Revenue of $9.07M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$9.07M
Net Income	$-2.20M
Cost of Goods Sold	$3.84M
Gross Profit	$5.22M
Operating Expenses	$10.19M
Operating Income	$-1.12M
Non-Operating Income/Expense	$-1.15M
Pre-Tax Income	$-2.27M
Normalized Pre-Tax Income	$-2.27M
Income after Taxes	$-2.20M
Income from Continuous Operations	$-2.20M
Consolidated Net Income/Loss	$-2.20M
Normalized Income after Taxes	$-2.20M
EBIT	$-1.12M
EBITDA	$-0.69M
Weighted-Average Shares Outstanding (Basic)	18.41M
Weighted-Average Shares Outstanding (Diluted)	18.41M
Earnings per Share (EPS) (Basic)	$-0.09
Earnings per Share (EPS) (Diluted)	$-0.09
Balance Sheet Financials
Current Assets	$30.50M
Property, Plant, and Equipment	$8.33M
Long-Term Assets	$17.16M
Total Assets	$47.66M
Current Liabilities	$7.68M
Long-Term Debt	$2.42M
Long-Term Liabilities	$14.53M
Total Liabilities	$22.22M
Common Equity	$25.45M
Tangible Shareholders Equity	$25.45M
Shareholders Equity	$25.45M
Common Shares Outstanding	22.67M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-7.23M
Cash Flow from Investing Activities	$-2.37M
Cash Flow from Financial Activities	$30.19M
Beginning Cash	$2.39M
End Cash	$23.02M
Increase/Decrease in Cash	$20.64M
Stock-Based Compensation	$0.60M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.97
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.09
Debt to Equity Ratio	0.10
Gross Margin	57.63%
Operating Margin	-12.36%
EBIT Margin	-12.36%
EBITDA Margin	--
Pre-Tax Profit Margin	-25.02%
Profit Margin	-24.31%
Free Cash Flow	$-9.58M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.19
Inventory Turnover	0.84
Receiveable Turnover	3.11
Days Sales in Receivables	28.95
Return on Equity	-8.66%
Return on Tangible Equity	-8.66%
Return on Assets	-4.62%
Return on Investments	-7.91%
Book Value Per Share	$1.12
Free Cash Flow per Share	$-0.52
Operating Cash Flow per Share	$-0.39

Data from Zacks Investment Research, Inc.